| Rajwant Kaur Panesar, ADMINISTRATOR | |
|
3700 Delta Fair Blvd Ste 200e, Antioch, CA 94509-4072 | |
| (209) 762-2910 | |
| (925) 303-2059 |
| Full Name | Rajwant Kaur Panesar |
|---|---|
| Gender | Female |
| Speciality | Licensed Vocational Nurse |
| Location | 3700 Delta Fair Blvd Ste 200e, Antioch, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265093116 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | 265646 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rajwant Kaur Panesar, ADMINISTRATOR 3700 Delta Fair Blvd Ste 200e, Antioch, CA 94509-4072 Ph: (209) 762-2910 | Rajwant Kaur Panesar, ADMINISTRATOR 3700 Delta Fair Blvd Ste 200e, Antioch, CA 94509-4072 Ph: (209) 762-2910 |
News Archive
A UCLA research team has shown that using a truncated form of the CD4 molecule as part of a gene therapy to combat HIV yielded superior and longer-lasting results in mouse models than previous similar therapies using the CD4 molecule.
Remember that sound bite you heard on the radio this morning? The grocery items your spouse asked you to pick up? Chances are, you won't.
Omeros Corporation today announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Immunoglobulin A (IgA) nephropathy.
Merck & Co., Inc. today announced financial results for the second quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the second quarter of $0.86, which excludes purchase accounting adjustments, merger-related expenses, restructuring costs and the gain on AstraZeneca's asset option exercise. Second-quarter GAAP EPS was $0.24.
EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that, following a recent meeting with the U.S. Food and Drug Administration (FDA) to discuss the Company's EMPOWER™ study results and the regulatory process, the Company intends to submit an Investigational Device Exemption (IDE) application for a clinical trial to support a possible Premarket Approval (PMA) application for the next-generation Maestro® RC System in the treatment of morbid obesity.
› Verified 7 days ago
Sandy Khristine Santos, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 1711 Kern Mountain Way, Antioch, CA 94531 Phone: 925-550-0163 | |
Mr. Wesley Keith Boone, L.V.N Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 3707 Sunset Ln, Antioch, CA 94509 Phone: 925-522-0124 | |
Arielle Marie Samuels, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 3707 Sunset Ln, Antioch, CA 94509 Phone: 925-522-0124 | |
Katherine Reyes, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 3707 Sunset Ln, Antioch, CA 94509 Phone: 925-522-0124 | |
Debra Rich, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 3707 Sunset Lane, Antioch, CA 94509 Phone: 925-522-0124 | |
Sarah Reyes, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 3707 Sunset Ln, Antioch, CA 94509 Phone: 925-522-0124 |